Priced Out by Protection: The Cruel Irony of Insurance Mandates and Who Really Pays for Them

There is a particular brand of political cruelty that arrives wearing the costume of compassion. Insurance mandates — the state and federal requirements that compel insurers to cover specific treatments, medications, therapies, and procedures — are perhaps the clearest modern example. Legislators announce them with press releases about expanded access and patient dignity. Actuaries absorb them into premium calculations. And ordinary Americans open their renewal notices and quietly wonder how coverage became something they can no longer afford.

The arithmetic is not complicated, though politicians prefer that voters never work through it. When government requires an insurance product to cover a broader set of services, the cost of that product rises. That is not a flaw in the insurance industry's character. It is arithmetic. And when the price of a mandatory product rises beyond what lower-income households can absorb, those households exit the market — not by choice, but by economic necessity.

The Mandate Proliferation Nobody Talks About

Most Americans have heard of the Affordable Care Act's essential health benefits requirements. Fewer are aware of the sprawling architecture of state-level mandates that existed long before federal intervention and that continue to layer additional obligations onto insurers operating within their borders. According to the Council for Affordable Health Insurance, states collectively impose hundreds of coverage mandates, ranging from requirements to cover in vitro fertilization and acupuncture to mandates for specific cancer screenings, autism therapies, and hair prostheses following chemotherapy.

Each of these mandates, viewed in isolation, can be made to sound unobjectionable. Who would argue against covering a cancer patient's wig? The problem is not any single mandate — it is the cumulative weight of all of them landing simultaneously on the actuarial table. When an insurer operating in a heavily mandated state calculates its premium, it is not pricing one sympathetic coverage requirement. It is pricing dozens of them, stacked atop one another, with administrative compliance costs included.

The result is a baseline product that is comprehensively generous and comprehensively expensive — a combination that serves the affluent reasonably well and the working poor not at all.

Who Actually Benefits From Mandated Comprehensiveness

Consider who is positioned to absorb rising premiums without fundamentally altering their financial lives. A dual-income household earning $180,000 annually in a metropolitan area can accommodate a $900 monthly premium as an unpleasant but manageable line item. A single parent earning $42,000 annually cannot. For that individual, the choice is not between comprehensive and basic coverage. It is between coverage and rent.

The uncomfortable truth that mandate advocates rarely confront is that their preferred policies actively manufacture this dilemma. By prohibiting insurers from offering stripped-down, lower-cost plans that cover catastrophic events without bundling in every legislatively fashionable therapy, regulators effectively outlaw the product that working-class Americans would voluntarily choose. The market is not failing these consumers. The market has been legally prevented from serving them.

High-deductible health plans have become the de facto refuge for those priced out of richer coverage, but even this option is increasingly constrained by mandate floors that prevent genuine cost competition. Meanwhile, the uninsured population — which mandate proponents perpetually invoke as justification for further regulation — remains stubbornly large, in part because the regulated product has become too expensive to function as genuine insurance for anyone without substantial disposable income or employer subsidization.

The Two-Tiered System Regulation Built

The irony is architectural. The regulatory apparatus designed to guarantee equitable access to healthcare has instead ratified a two-tiered system that would embarrass its architects if they were willing to examine outcomes rather than intentions.

At the top tier sit those with employer-sponsored plans at large corporations, government employees with generous public benefits, and individuals wealthy enough to absorb whatever the mandated premium environment demands. These Americans enjoy comprehensive coverage and largely experience the mandate regime as invisible — the costs are either shared across a large employer pool or simply affordable relative to their income.

At the bottom tier sit the self-employed, workers at small businesses that cannot afford to offer benefits, gig economy participants, and anyone whose income falls into the awkward range above subsidy thresholds but below genuine affordability. These Americans face a market in which the law has made inexpensive, functional coverage illegal and in which the mandated alternative consumes a disproportionate share of their earnings. Many choose the penalty — or, since the federal individual mandate penalty was effectively zeroed out, simply go without.

This is not a market failure. This is a regulatory failure presenting itself as a market failure, a distinction that matters enormously if one is interested in solutions rather than further rounds of the same intervention.

What a Free Market in Coverage Would Actually Look Like

The alternative that mandate proponents refuse to seriously engage with is a genuine market in health insurance products — one in which consumers, rather than legislators, determine what coverage they need and what they can afford. In such a market, a young healthy individual could purchase a catastrophic-only plan at a premium reflecting actual actuarial risk. A family managing a chronic condition could purchase richer coverage calibrated to their specific circumstances. Prices would reflect choices, and choices would reflect individual circumstances rather than legislative preferences.

Critics immediately raise the specter of adverse selection — the concern that only the sick will buy rich coverage, destabilizing risk pools. This is a legitimate actuarial concern, but it is one that market mechanisms and properly structured high-risk pools can address without mandating that every American purchase a product priced for someone else's healthcare consumption profile. States that have experimented with deregulated insurance markets have demonstrated that price competition, when permitted to operate, produces options that genuinely expand access rather than merely mandating comprehensiveness that prices access away.

The deeper issue is one of philosophical honesty. If legislators wish to ensure that specific treatments are available to low-income Americans, the direct and transparent mechanism is public subsidy — funded through explicit taxation, subject to democratic accountability, and visible in the budget. The mandate approach instead launders that subsidy through private premiums, hiding the cost in the price of a product and allowing legislators to claim they have guaranteed access without acknowledging what they have done to affordability.

The Cost of Good Intentions

Free markets are not indifferent to suffering. They are, however, honest about tradeoffs in a way that regulatory mandates are not. A market that offers consumers genuine choices — including the choice to purchase less comprehensive coverage at a lower price — is not a market that abandons the vulnerable. It is a market that respects their economic agency and their capacity to determine their own priorities.

The mandate trap persists because it is politically costless to impose and politically painful to repeal. No legislator wants to be characterized as having voted to eliminate coverage for a sympathetic condition. But the Americans who have been quietly priced out of the insurance market by the cumulative weight of those compassionate mandates deserve an honest accounting of what that political calculus has cost them.

Comprehensive coverage that no one can afford is not a healthcare achievement. It is a rhetorical one. The Free Enterprise Nation believes Americans deserve the real thing.